Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Ali Zahit Bolaman"'
Autor:
Müzeyyen Aslaner Ak, Ayfer Gedük, İbrahim Halil Açar, Merve Gökçen Polat, Cenk Sunu, Ali Zahit Bolaman, Tuba Hacıbekiroğlu, Birol Güvenç, Şehmus Ertop
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 2, Pp 92-100 (2023)
Objective: This study was undertaken to evaluate the long-term clinical efficacy of epoetin alfa and darbepoetin alfa in patients with myelodysplastic syndrome (MDS) in a real-life setting. Materials and Methods: A total of 204 patients with low-ris
Externí odkaz:
https://doaj.org/article/119cab3394ef41ee9f63074b936f7071
Autor:
Müzeyyen Aslaner Ak, Birsen Sahip, Ayfer Geduk, Mehmet Ali Uçar, Hacer Kale, Tugba Hacibekiroglu, Merve Gokcen Polat, Yasin Kalpakcı, Ali Zahit Bolaman, Birol Guvenc, Sehmus Ertop
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S39- (2023)
Objective: This study aimed to evaluate the clinical efficacy of epoetin alfa and darbepoetin alfa in patients with myelodysplastic syndromes (MDS) in the real-life setting. Methodology: A total of 204 patients with low-risk or intermediate-1-risk MD
Externí odkaz:
https://doaj.org/article/f26c375c8e1b494c8bd32d78d235c81f
Autor:
İbrahim Halil Erdoğdu, Seda Örenay-Boyacıoğlu, Olcay Boyacıoğlu, Nesibe Kahraman-Çetin, Füruzan Kacar-Döger, İrfan Yavaşoğlu, Ali Zahit Bolaman
Publikováno v:
Journal of Personalized Medicine, Vol 14, Iss 2, p 140 (2024)
Malignant diseases occurring in elderly patients follow a different course from younger patients and show different genetic structures. Therefore, in this retrospective study, the somatic gene variant profile and fusion gene profiles of elderly and y
Externí odkaz:
https://doaj.org/article/e41659ee28f54838a46a4e6c268da1e1
Publikováno v:
Türkiye Parazitoloji Dergisi, Vol 47, Iss 2, Pp 127-128 (2023)
Externí odkaz:
https://doaj.org/article/aab5141fc6324c50984ca4173f7e5c25
Autor:
Sinem Civriz Bozdağ, Güldane Cengiz Seval, İpek Yönal Hindilerden, Fehmi Hindilerden, Neslihan Andıç, Mustafa Baydar, Lale Aydın Kaynar, Selami Koçak Toprak, Hasan Sami Göksoy, Berrin Balık Aydın, Ufuk Demirci, Ferda Can, Vildan Özkocaman, Eren Gündüz, Zeynep Tuğba Güven, Zübeyde Nur Özkurt, Sinan Demircioğlu, Meral Beksaç, İdris İnce, Umut Yılmaz, Hilal Eroğlu Küçükdiler, Elgün Abishov, Boran Yavuz, Ünal Ataş, Yaşa Gül Mutlu, Volkan Baş, Fahir Özkalemkaş, Hava Üsküdar Teke, Vildan Gürsoy, Serhat Çelik, Rafiye Çiftçiler, Münci Yağcı, Pervin Topçuoğlu, Özcan Çeneli, Hamza Abbasov, Cem Selim, Muhlis Cem Ar, Orhan Kemal Yücel, Sevil Sadri, Canan Albayrak, Ahmet Muzaffer Demir, Nil Güler, Muzaffer Keklik, Hatice Terzi, Ali Doğan, Zeynep Arzu Yegin, Meltem Kurt Yüksel, Soğol Sadri, İrfan Yavaşoğlu, Hüseyin Saffet Beköz, Tekin Aksu, Senem Maral, Veysel Erol, Leylagül Kaynar, Osman İlhan, Ali Zahit Bolaman, Ömür Gökmen Sevindik, Arzu Akyay, Muhit Özcan, Günhan Gürman, Şule Ünal, Yasemin Yavuz, Reyhan Diz Küçükkaya, Güner Hayri Özsan
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 1, Pp 43-54 (2022)
Objective: Patients with solid malignancies are more vulnerable to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection than the healthy population. The outcome of SARS-CoV-2 infection in highly immunosuppressed populations, such as
Externí odkaz:
https://doaj.org/article/ef03a300a9a44beba39b3be598d50f71
Autor:
Ali Zahit Bolaman, Atakan Turgutkaya, Birsen Sahip, Cem Selim, Ayşe Hilal Eroğlu Küçükdiler, Şehmus Ertop, Gökhan Sargın, İrfan Yavaşoğlu
Publikováno v:
Turkish Journal of Hematology, Vol 38, Iss 1, Pp 41-48 (2021)
Objective: Lenalidomide is an effective immunomodulatory derivative drug used in the treatment of multiple myeloma (MM). It is available in original and generic forms in Turkey, but there is no clinical study that has compared the effectiveness and a
Externí odkaz:
https://doaj.org/article/0f0e1be7ab3747338cff9232f00fec65
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S17-S18 (2021)
Objective: Multiple myeloma(MM) is a malignancy of clonal plasma cells. Osteolytic lesions represent a criterion for symptomatic myeloma and are associated with bone loss, pathological fractures, and osteoporosis. Skeletal surveys with other sophisti
Externí odkaz:
https://doaj.org/article/2c0341b5b6fe4fc7aaf309656f0466df
Publikováno v:
Plasmatology, Vol 15 (2021)
Transfusion-related acute lung injury (TRALI) is an undesired and potentially fatal complication of blood transfusion. Besides human neutrophil and leukocyte antigens of the donor blood; especially for red blood cell transfusions, nonantibody-mediate
Externí odkaz:
https://doaj.org/article/a7f8a7b0a0944624af9cddf23377b967
Publikováno v:
Plasmatology, Vol 15 (2021)
Purpose Daratumumab, a monoclonal anti-CD38 antibody, has been administered for relapsed refractory multiple myeloma (RRMM). The Pollux and Castor trials proved its efficacy, yet excluded patients with advanced-stage renal disease. Therefore, availab
Externí odkaz:
https://doaj.org/article/180791830cf8465c9263d06950f41bd1
Autor:
Ayşe Hilal Eroğlu Küçükdiler, İrfan Yavaşoğlu, Cem Selim, Cansu Atmaca Mutlu, Abdullah Karakuş, Mahmut Bakır Koyuncu, Oktay Bilgir, Orhan Ayyıldız, Eyüp Naci Tiftik, Ali Zahit Bolaman
Publikováno v:
Leukemia Research Reports, Vol 16, Iss , Pp 100280- (2021)
We retrospectively evaluated the use of gemtuzumab ozogamicin (GO) in relapsed refractory (R/R) acute myeloid leukemia (AML) patients. Twenty-one CD33 positive R/R AML patients who received GO as a single agent in 4 hematology centers were included i
Externí odkaz:
https://doaj.org/article/45ce0eecfb3e4771bd9551a8db580cf6